# Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

> **NCT02010788** · — · COMPLETED · sponsor: **Allergan** · enrollment: 523 (actual)

## Conditions studied

- Urinary Incontinence
- Urinary Bladder, Overactive

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A

## Key facts

- **NCT ID:** NCT02010788
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 523 (ACTUAL)
- **Last updated:** 2016-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02010788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02010788, "Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02010788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*